PT829262E - Utilizacao de inibidores de pkc para o fabrico de um medicamento para o tratamento de disfuncoes sexuais. - Google Patents

Utilizacao de inibidores de pkc para o fabrico de um medicamento para o tratamento de disfuncoes sexuais.

Info

Publication number
PT829262E
PT829262E PT97306425T PT97306425T PT829262E PT 829262 E PT829262 E PT 829262E PT 97306425 T PT97306425 T PT 97306425T PT 97306425 T PT97306425 T PT 97306425T PT 829262 E PT829262 E PT 829262E
Authority
PT
Portugal
Prior art keywords
manufacture
treatment
medicinal product
pkc inhibitors
sexual diseases
Prior art date
Application number
PT97306425T
Other languages
English (en)
Inventor
Michael R Jirousek
Douglas Kirk Ways
Lawrence E Stramm
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT829262E publication Critical patent/PT829262E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PT97306425T 1996-08-22 1997-08-22 Utilizacao de inibidores de pkc para o fabrico de um medicamento para o tratamento de disfuncoes sexuais. PT829262E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2342596P 1996-08-22 1996-08-22
US08/915,303 US6093709A (en) 1996-08-22 1997-08-19 Therapeutic treatment for sexual dysfunctions

Publications (1)

Publication Number Publication Date
PT829262E true PT829262E (pt) 2002-06-28

Family

ID=26697133

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97306425T PT829262E (pt) 1996-08-22 1997-08-22 Utilizacao de inibidores de pkc para o fabrico de um medicamento para o tratamento de disfuncoes sexuais.

Country Status (21)

Country Link
US (1) US6093709A (pt)
EP (1) EP0829262B1 (pt)
JP (1) JP2001500478A (pt)
KR (1) KR20000068279A (pt)
AT (1) ATE210981T1 (pt)
AU (1) AU731260B2 (pt)
BR (1) BR9711210A (pt)
CA (1) CA2263556A1 (pt)
CZ (1) CZ52399A3 (pt)
DE (2) DE69709273T2 (pt)
DK (1) DK0829262T3 (pt)
EA (1) EA001836B1 (pt)
ES (1) ES2122953T3 (pt)
IL (1) IL128495A0 (pt)
NO (1) NO990794L (pt)
NZ (1) NZ334609A (pt)
PL (1) PL331849A1 (pt)
PT (1) PT829262E (pt)
TR (1) TR199900904T2 (pt)
WO (1) WO1998007422A1 (pt)
YU (1) YU7799A (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756136B2 (en) * 1997-06-23 2003-01-02 Queen's University At Kingston Microdose therapy
CA2340206A1 (en) * 1998-08-26 2000-03-09 Queen's University At Kingston Use of anti-pressor agents for vascular remodeling in genital dysfunction
GB0004549D0 (en) * 2000-02-25 2000-04-19 Isis Innovation Degradation fragments
EP2177510A1 (en) 2008-10-17 2010-04-21 Universität des Saarlandes Allosteric protein kinase modulators
US8652129B2 (en) * 2008-12-31 2014-02-18 Medtronic Ardian Luxembourg S.A.R.L. Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
AU2013230906A1 (en) * 2012-03-08 2014-09-18 Medtronic Af Luxembourg S.A.R.L. Neuromodulation and associated systems and methods for the treatment of sexual dysfunction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278989B6 (sk) * 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
YU49200B (sh) * 1993-12-07 2004-09-03 Eli Lilly And Company Inhibitori proteinske kinaze c
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5658936A (en) * 1995-09-18 1997-08-19 Brigham & Women's Hospital, Inc. Enhancement of erectile function with renin-angiotensin system inhibitors

Also Published As

Publication number Publication date
NO990794L (no) 1999-04-21
NZ334609A (en) 1999-11-29
DE829262T1 (de) 1999-04-22
TR199900904T2 (xx) 1999-07-21
DK0829262T3 (da) 2002-03-18
DE69709273T2 (de) 2002-08-14
YU7799A (sh) 2000-03-21
DE69709273D1 (de) 2002-01-31
EA199900220A1 (ru) 1999-08-26
IL128495A0 (en) 2000-01-31
ES2122953T1 (es) 1999-01-01
EP0829262A2 (en) 1998-03-18
ATE210981T1 (de) 2002-01-15
EA001836B1 (ru) 2001-08-27
KR20000068279A (ko) 2000-11-25
JP2001500478A (ja) 2001-01-16
CZ52399A3 (cs) 1999-12-15
US6093709A (en) 2000-07-25
AU731260B2 (en) 2001-03-29
AU4157597A (en) 1998-03-06
NO990794D0 (no) 1999-02-19
BR9711210A (pt) 1999-08-17
EP0829262B1 (en) 2001-12-19
WO1998007422A1 (en) 1998-02-26
PL331849A1 (en) 1999-08-16
ES2122953T3 (es) 2002-07-01
EP0829262A3 (en) 1998-03-25
CA2263556A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
EA199800971A1 (ru) Способ лечения новообразований, вкючающий применение ингибиторов протеиназы с
NO985067D0 (no) Terapeutisk behandling for VEGF-relaterte °yesykdommer
DE69735134D1 (de) Therapeutische behandlung von kardiovaskularen krankheiten
PT829262E (pt) Utilizacao de inibidores de pkc para o fabrico de um medicamento para o tratamento de disfuncoes sexuais.
EP0940141A3 (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection
EA199900245A1 (ru) Использование ингибиторов протеинкиназы с для получения лекарственного препарата для лечения спида
DE69935881D1 (de) Bis-Indolylmaleimide zur therapeutischen Behandlung von Nieren-Funktionsstörungen
EP0940143A3 (en) Use of PKC-inhibitors for the manufacture of a medicament for the treatment of asthma
NO990947L (no) Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon
EA199900243A1 (ru) Применение ингибиторов протеинкиназы с для производства лекарственного препарата для лечения инфекции, вызванной человеческим т-клеточным лимфотропным вирусом типа 1